General Hospital Psychiatry
Volume 25, Issue 1 , Pages 27-33 , January 2003

Steroid psychosis: a review

  • François Sirois, M.D.

      Affiliations

    • Department of Psychiatry, Hôpital Laval, Sainte-Foy, Québec, Canada
    • Corresponding Author InformationCorresponding author. Tel.: 418-656-4565; fax: 418-656-4551.

References 

  1. Rome HP, Braceland FJ. The psychological response to ACTH cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry. 1952;108:641–651
  2. Rome HP, Braceland FJ. Use of cortisone, and ACTH in certain diseases (psychiatric aspects). Proc Staff Meet Mayo Clinic. 1950;25:495–497
  3. Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone, and ACTH. N Engl J Med. 1952;246:205–216
  4. Lewis A, Fleminger JJ. The psychiatric risk from corticotrophin, and cortisone. Lancet. 1954;i:383–386
  5. Clark LD, Quarton GC, Cobb S, et al.  Further observations on mental disturbances associated with cortisone, and ACTH therapy. N Engl J Med. 1953;249:178–183
  6. Smyllie HC, Connoly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax. 1968;23:571–581
  7. Brown ES, Suppes T. Moood symptoms during corticosteroid therapy (a review). Harvard Review Psychiatry. 1998;5:239–241
  8. Kirsner JB, Palmer WL, Spencer JA, et al.  Corticotropin (ACTH), and the adrenal steroids in the management of ulcerative colits –observations in 240 patients. Ann Intern Med. 1959;50:891–927
  9. Marx FW, Barker WF. Surgical results in patients with ulcerative colitus treated with, and without corticosteroids. Am J Surg. 1967;113:157–163
  10. Neilsen JB, Drivsholm A, Fisher F, et al.  Long-term treatment with corticosteroids in rheumatoid arthritis (over a period of 9 to 12 years). Acta Med Scand. 1963;173:177–183
  11. Bunim JJ, Ziff M, McEwen C. Evaluation of prolonged cortisone therapy in rheumatoid arthritis. Amer J Med. 1955;18:27–40
  12. Hall RCW, Popkin MK, Suckney SK, et al.  Presentation of the steroid psychoses. J Nerv Ment Dis. 1979;167:229–236
  13. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes (a report of 14 cases, and a review of the literature). J Affect Disord. 1983;5:319–332
  14. Cade R, Spooner G, Schlern E, et al.  Comparison of azathroprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron. 1973;10:37–56
  15. Villareal SV, Escande M, Levet C. À. propos des psychoses cortisoniques. Ann Med Psychol. 1974;132:523–530
  16. Wada K, Yamada N, Suzuki K, et al.  Recurrent Cases of Corticosteroid -induced Mood Disorders (clinical characteristics and treatment). J Clinical Psychiatry. 2000;61:261–267
  17. Wada K, Yamada N, Sato T, et al.  Corticosteroid -induced Mood Disorders. Psychosomatics. 2001;42:461–466
  18. Sharfstein SS, Sack DS, Fauci AS. Relationship between alternate-day corticosteroid therapy, and behavioral abnormalities. JAMA. 1982;248:2987–2989
  19. Stoudemire A, Anfinson T, Edwards J. Corticosteroid-induced delirium, and dependency. Gen Hosp Psychiatry. 1996;18:196–202
  20. Finkenbine R, Gill HS. Case of mania due to prednisone-clarithomycin interaction. (letter) Can J Psychiatry. 1997;42:778
  21. The Boston Collaborative Drug Surveillance Program . Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972;13:694–698
  22. Sergent JS, Lockshun MD, Klempner MS, et al.  Central nervous system disease in systemic lypus erythematosus –therapy, and prognosis. Amer J Med. 1975;58:644–654
  23. Rosenberg FR, Sanders S, Nelson CT. Pemphigus –A 20-year review of 107 patients treated with corticosteroids. Arch Dermatol. 1976;148:962–970
  24. Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotrophin-induced psychosis. JAMA. 1979;241(10):1011–1012
  25. Brown S, Khan D, Nejtek VA. The psychiatric side effects of corticosteroids. Annals Allergy, Asthma, Immulogy. 1999;83:495–504
  26. Patten SB, Neutel I. Corticosteroid-induced adverse psychiatric effects. Drug Safety. 2000;22:111–122
  27. Haskett RF. Diagnostic characterization of psychiatric disability in Cushing’s syndrome. Amer J Psychiatry. 1985;142:911–916
  28. Hudson JI, Hudson MS, Greffing GT, et al.  Phenomenology, and family history of affective disorder in Cushing’s disease. Am J Psychiatry. 1987;144:951–953
  29. Swinburn CR, Wakefield JM, Newman SP, et al.  Evidence of prednisolone induced mood change (steroid euphoria) in patients with chronic obstructive airways disease. Br J Clin Pharmacol. 1988;26:709–713
  30. Brown ES, Suppes T, Khan DA, Carmody TJ. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacology. 2002;22:55–61
  31. Naber D, Sand P, Heigi B. Psychopathological, and neuropsychological effects of 8-days corticosteroid treatment (a prospective study). Psychoneuroendocrinology. 1996;21:25–31
  32. Keenan PA, Jacobson MW, Soleymani RM, et al.  The effects on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47(6):1396–1402
  33. Wolkowitz OM, Reus UI, Weingartner U, et al.  Cognitive effects of corticosteroids. Am. J. Psychiatry. 1990;147:1297–1303
  34. Newcomer JW, Craft S, Hershey T, et al.  Glucocorticoid induced impairments in declarative memory performance in adult humans. J Neurosci. 1991;14:2047–2053
  35. Varney NR, Alexander B, MacIndoe JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry. 1994;141:369–372
  36. Stiefel FC, Breitbart W, Holland JC. Corticosteroids in cancer. Neuropsychiatric Complications. Cancer Investigation. 1989;7:479–491
  37. Campbell KM, Schubert DSP. Delirium after cessation of glucocorticoid therapy. Gen Hosp Psychiatry. 1991;13:270–272
  38. Baloch N. Steroid psychosis (a case report). Br J Psychiatry. 1974;124:545–546
  39. Freyberg RH, et al.  Problems of prolonged cortisone treatment for rhumatoid arthritis. JAMA. 1951;147:1538–1543
  40. Wolkowitz OM. Long-lasting behavioral changes following Prednisone withdrawal. JAMA. 1989;261:1731
  41. Dixon R, Christy N. On the various forms of corticosteroid withdrawal syndrome. Amer J Medicine. 1980;68:224–240
  42. Venkatarangam SHM, Kutcher SP, Notkin RM. Secondary mania with steroid withdrawal. Can J Psychiatry. 1988;33:631–632
  43. Pies R. Persistent bipolar illness after steroid administration. Arch Intern Med. 1981;141:1087
  44. Glyne-Jones R, Vernon CC, Bell G. Is steroid psychosis preventable by divided doses. (letter) Lancet. 1986;ii:1404
  45. Tomson CRV, Jenning MC. Prednisolone pharmacokinetics, and steroid psychosis. Lancet. 1987;i:270
  46. Mermelstein HT. Clarithromycin –induced delirium in a general hospital. Psychosomatics. 1998;39:540–542
  47. Wysenbeck AJ, Leiborici L, Zoldan S. Acute central nervous system complication of pulse steroid therapy in patients with SLE. J Rhumatology. 1990;17:1695–1696
  48. Wolhein FA. Acute, and long-term complications of corticosteroid pulse therapy. Scand J Rheumatology. 1984;54:27–32
  49. Hall RCW, Popkin MK, Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis. 1978;166:738–742
  50. Goggans FC, Weisberg LJ, Koran LM. Lithium prophylaxis of prednisone psychosis (a case report). J Clin Psychiatry. 1983;44:111–112
  51. Siegal FP. Lithium for steroid-induced psychosis. (letter) N Engl J Med. 1978;299:155–156
  52. Abbas A, Stryra R. Valproate prophylaxis against steroid induced psychosis. (letter) Can J Psychiatry. 1994;39:188–189
  53. Wyszynski AA, Wyszynski B. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjögren’s syndrome. Psychosomatics. 1993;34(2):173–177
  54. Brown ES, Khan DA, Suppes T. Treatment of corticosteroid induced mood changes with olanzapine. Am. J. Psychiatry. 1999;156:968
  55. Dasilva CC, Murse MC, Vokey K. Steroid induced Psychosis treated with risperidone. Can J Psychiatry. 2002;47:388–389

PII: S0163-8343(02)00241-4

doi: 10.1016/S0163-8343(02)00241-4

General Hospital Psychiatry
Volume 25, Issue 1 , Pages 27-33 , January 2003

Article Tools